NO942606L - Anvendelse av fenalkylaminer - Google Patents
Anvendelse av fenalkylaminerInfo
- Publication number
- NO942606L NO942606L NO942606A NO942606A NO942606L NO 942606 L NO942606 L NO 942606L NO 942606 A NO942606 A NO 942606A NO 942606 A NO942606 A NO 942606A NO 942606 L NO942606 L NO 942606L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halogen
- formula
- atom
- image
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH210793 | 1993-07-14 | ||
| CH132094 | 1994-04-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO942606D0 NO942606D0 (no) | 1994-07-12 |
| NO942606L true NO942606L (no) | 1995-01-16 |
| NO309924B1 NO309924B1 (no) | 2001-04-23 |
Family
ID=25687322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942606A NO309924B1 (no) | 1993-07-14 | 1994-07-12 | Anvendelse av fenalkylaminer og nye fenylalkylaminer |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US5495048A (no) |
| EP (1) | EP0636367B1 (no) |
| JP (1) | JP2519022B2 (no) |
| KR (1) | KR100312441B1 (no) |
| CN (1) | CN1087934C (no) |
| AT (1) | ATE191142T1 (no) |
| AU (1) | AU684507B2 (no) |
| CA (1) | CA2126518C (no) |
| CZ (1) | CZ288518B6 (no) |
| DE (1) | DE59409248D1 (no) |
| DK (1) | DK0636367T3 (no) |
| ES (1) | ES2144471T3 (no) |
| GR (1) | GR3033645T3 (no) |
| HU (1) | HUT70835A (no) |
| IL (1) | IL110254A (no) |
| NO (1) | NO309924B1 (no) |
| NZ (1) | NZ260968A (no) |
| PH (1) | PH31092A (no) |
| PT (1) | PT636367E (no) |
| RU (1) | RU2141942C1 (no) |
| TW (1) | TW438774B (no) |
| UA (1) | UA37199C2 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
| CA2190699A1 (en) | 1995-12-08 | 1997-06-09 | Johannes Aebi | Tertiary amines |
| CN1208329C (zh) * | 2000-07-18 | 2005-06-29 | 弗·哈夫曼-拉罗切有限公司 | 新的苯胺衍生物 |
| DE60135230D1 (de) | 2000-08-16 | 2008-09-18 | Hoffmann La Roche | Aminocyclohexan-derivate |
| US6964974B2 (en) | 2000-09-08 | 2005-11-15 | Hoffmann-La Roche Inc. | 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| US6503907B2 (en) * | 2000-11-28 | 2003-01-07 | Hoffmann-La Roche Inc. | Indole and dihydroindole derivatives |
| US6706751B2 (en) * | 2000-12-21 | 2004-03-16 | Hoffman-La Roche Inc. | Dihydroindole and tetrahydroquinoline derivatives |
| JP4124736B2 (ja) * | 2001-12-12 | 2008-07-23 | エフ．ホフマン−ラ ロシュ アーゲー | 置換シクロヘキサン誘導体 |
| US7012077B2 (en) * | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
| US6727277B1 (en) | 2002-11-12 | 2004-04-27 | Kansas State University Research Foundation | Compounds affecting cholesterol absorption |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| AU2004274155A1 (en) * | 2003-09-22 | 2005-03-31 | F. Hoffmann-La Roche Ag | Aminoalkylamide substituted cyclohexyl derivatives |
| CN101583593A (zh) * | 2006-11-13 | 2009-11-18 | 辉瑞产品公司 | 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途 |
| CN108530390B (zh) * | 2017-03-06 | 2020-04-21 | 西南化工研究设计院有限公司 | 一种4-羟基二苯甲酮的烷基化方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647863A (en) * | 1968-11-25 | 1972-03-07 | Richardson Merrell Inc | Aminoalkoxy-triphenyl ethylenes and the salts thereof |
| US3928449A (en) * | 1969-04-03 | 1975-12-23 | Sandoz Ag | Aminoalkoxy-terphenyls and the salts thereof |
| CA2016738A1 (en) * | 1989-06-08 | 1990-12-08 | Philippe Guerry | Substituted aminoalkylbenzene derivatives |
| US5214046A (en) * | 1989-07-27 | 1993-05-25 | Hoffmann-La Roche Inc. | Substituted aminoalkoxybenzene anti-fungicidal compositions and use |
| CA2020888A1 (en) * | 1989-07-27 | 1991-01-28 | Philippe Guerry | Substituted aminoalkoxybenzene derivatives |
| US5239084A (en) * | 1990-06-29 | 1993-08-24 | Hoffmann-La Roche Inc. | Substituted aminoalkyl biphenyl compounds |
| CA2044533A1 (en) * | 1990-06-29 | 1991-12-30 | Philippe Guerry | Substituted aminoalkylbiphenyl derivatives |
-
1994
- 1994-06-16 TW TW083105454A patent/TW438774B/zh not_active IP Right Cessation
- 1994-06-17 US US08/261,615 patent/US5495048A/en not_active Expired - Fee Related
- 1994-06-22 CA CA002126518A patent/CA2126518C/en not_active Expired - Fee Related
- 1994-07-01 EP EP94110246A patent/EP0636367B1/de not_active Expired - Lifetime
- 1994-07-01 DE DE59409248T patent/DE59409248D1/de not_active Expired - Fee Related
- 1994-07-01 AT AT94110246T patent/ATE191142T1/de not_active IP Right Cessation
- 1994-07-01 DK DK94110246T patent/DK0636367T3/da active
- 1994-07-01 PT PT94110246T patent/PT636367E/pt unknown
- 1994-07-01 ES ES94110246T patent/ES2144471T3/es not_active Expired - Lifetime
- 1994-07-08 RU RU94026094/04A patent/RU2141942C1/ru not_active IP Right Cessation
- 1994-07-08 JP JP6157038A patent/JP2519022B2/ja not_active Expired - Fee Related
- 1994-07-08 NZ NZ260968A patent/NZ260968A/en unknown
- 1994-07-08 AU AU67358/94A patent/AU684507B2/en not_active Ceased
- 1994-07-08 IL IL110254A patent/IL110254A/en not_active IP Right Cessation
- 1994-07-12 CZ CZ19941676A patent/CZ288518B6/cs not_active IP Right Cessation
- 1994-07-12 PH PH48609A patent/PH31092A/en unknown
- 1994-07-12 NO NO942606A patent/NO309924B1/no unknown
- 1994-07-13 UA UA94075630A patent/UA37199C2/uk unknown
- 1994-07-13 KR KR1019940016823A patent/KR100312441B1/ko not_active IP Right Cessation
- 1994-07-13 CN CN94108447A patent/CN1087934C/zh not_active Expired - Fee Related
- 1994-07-13 HU HU9402085A patent/HUT70835A/hu unknown
-
1995
- 1995-06-06 US US08/468,114 patent/US5574071A/en not_active Expired - Fee Related
- 1995-11-08 US US08/555,054 patent/US5637771A/en not_active Expired - Fee Related
-
2000
- 2000-06-12 GR GR20000401332T patent/GR3033645T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL110254A0 (en) | 1994-10-21 |
| KR100312441B1 (ko) | 2002-10-31 |
| UA37199C2 (uk) | 2001-05-15 |
| ATE191142T1 (de) | 2000-04-15 |
| KR960014096A (ko) | 1996-05-22 |
| IL110254A (en) | 1998-04-05 |
| US5495048A (en) | 1996-02-27 |
| AU684507B2 (en) | 1997-12-18 |
| RU94026094A (ru) | 1996-05-20 |
| US5574071A (en) | 1996-11-12 |
| CZ288518B6 (cs) | 2001-07-11 |
| DE59409248D1 (de) | 2000-05-04 |
| AU6735894A (en) | 1995-01-27 |
| CA2126518C (en) | 2006-11-21 |
| CN1087934C (zh) | 2002-07-24 |
| EP0636367B1 (de) | 2000-03-29 |
| RU2141942C1 (ru) | 1999-11-27 |
| HU9402085D0 (en) | 1994-09-28 |
| TW438774B (en) | 2001-06-07 |
| CZ167694A3 (en) | 1995-01-18 |
| US5637771A (en) | 1997-06-10 |
| NZ260968A (en) | 1996-06-25 |
| PH31092A (en) | 1998-02-05 |
| PT636367E (pt) | 2000-07-31 |
| EP0636367A1 (de) | 1995-02-01 |
| GR3033645T3 (en) | 2000-10-31 |
| DK0636367T3 (da) | 2000-07-31 |
| ES2144471T3 (es) | 2000-06-16 |
| JP2519022B2 (ja) | 1996-07-31 |
| NO309924B1 (no) | 2001-04-23 |
| HUT70835A (en) | 1995-11-28 |
| NO942606D0 (no) | 1994-07-12 |
| CA2126518A1 (en) | 1995-01-15 |
| CN1103781A (zh) | 1995-06-21 |
| JPH0753479A (ja) | 1995-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942606D0 (no) | Anvendelse av fenalkylaminer | |
| DK0565549T3 (da) | Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B | |
| FI955828A0 (fi) | Uusia peptidijohdannaisia | |
| FI914928A (fi) | Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner. | |
| ATE179706T1 (de) | N-heteroaryl-n'-phenylharnstoffderivate, ihre herstellung und verwendung | |
| FI911286A0 (fi) | Kemiska foereningar. | |
| NO934536D0 (no) | Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler | |
| ATE157088T1 (de) | Neue chinolon- und naphthyridoncarbonsäurederivate | |
| NO943521D0 (no) | Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum | |
| ES2160649T3 (es) | Nuevos compuestos lactamicos y procedimientos para su preparacion. | |
| DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| AU625238B2 (en) | Anti-psychotic piperidylbenzimidazole compounds | |
| ATE192141T1 (de) | Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung | |
| PT78155A (de) | N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung | |
| DE69305330D1 (de) | Aminoalkylchomone, Verfahren für ihre Herstellung und die enthaltende pharmazeutische Zusammensetzungen | |
| NO842003L (no) | Substituerte isokinolinderivater | |
| DE69505756D1 (de) | Verfahren zur Herstellung von (-)-N-methyl-N-[4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-benzamid und ihr pharmazeutisch annehmbares Salz | |
| DE69320542D1 (de) | Pyrrolothienopyrazin-Verbindungen als 5HT3-Rezeptoren-Antagonisten | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| IT1245631B (it) | Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina |